Pharmacoeconomics: Principles and Practice

Lorenzo Pradelli is medical director at AdRes Health Economics and Outcomes Research srl, Torino, Italy. He is in charge of the design, development and management of pharmacoeconomic researches, with particular reference to the medical and scientific aspects. He is member of the scientific board of Farmeconomia. Health economics and therapeutic pathways, published by SEEd. He’s author and co-author of more than 100 articles on pharmacoeconomics, including original scientific papers in peer-reviewed journals, oral communications and poster presentations at national and international congresses. Dr. Pradelli is member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the Italian Society for the study of Drug Economics and Ethics and Therapeutic Intervention (SIFEIT).

Albert Wertheimer is an adjunct professor of social and administrative pharmacy at Nova Southeastern University in Ft. Lauderdale, Florida, USA and a visiting professor at the Touro College of Pharmacy in New York City. Previously, he was a professor of pharmacy economics at the school of pharmacy at Temple University, Philadelphia, PA, USA, and he was a professor at the University of Minnesota, Dean at the Philadelphia College of Pharmacy, Director of Health Outcomes Management at Merck and Company, and a vice president at First Health, a pharmacy benefit management (PBM) firm. He received a Bachelor of Pharmacy degree from the University of Buffalo; a Masters of Business Administration from the State University of New York at Buffalo, and a PhD degree from Purdue University. He was also a post-doctoral fellow at the Department of Social Medicine at St. Thomas’ Hospital Medical School of the University of London (UK). He is the author or co-author of 31 books, 410 articles in scientific and professional journals and 30 book chapters. He has directed 85 Ph.D. students and a similar number of Masters degree students. Professor Wertheimer has consulted or lectured in over 60 countries. He holds visiting or adjunct professorships at Universities in Taiwan, Turkey, China, Mexico, Malaysia, among others. He is the editor of the quarterly journal, Journal of Pharmaceutical Health Services Research, published by Wiley-Blackwell. He has been the recipient of numerous international awards such as a Scheele Laureate from the Swedish Academy of Pharmaceutical Sciences, Fellowship in the Mexican Academy of Pharmaceutical Sciences, the André Bédat Award from the International Pharmacy Federation (FIP), research achievement award from the American Pharmacists Association, and Fellowship from the American Association of Pharmaceutical Scientists.
Dr. Wertheimer maintains an active consulting practice where he assists pharmaceutical companies, governmental and international agencies, professional societies and other clients. He lives in Naples, Florida, USA and may be contacted at: albertw@rcn.com

Ceri Phillips was Professor of Health Economics at Swansea University Centre for Health Economics and Head of Research at the College of Human and Health Sciences, Swansea University, Wales. He was a non-executive member of Abertawe Bro Morgannwg Health Board and a member of the Bevan Commission, established by the Welsh Minister of Health and Social Services on the 60th anniversary of the NHS to advise and oversee the new configuration and structure of NHS Wales. He was also a member of the 1000 Lives+ Programme Board and the Management Board of the NICE Collaborating Centre for Cancer and had been a member of NICE Programme Development Groups on a range of public health issues. Up until November 2011 he was the health economics member of the All Wales Medicines Strategy Group (AWMSG), which advises the Welsh Minster of Health and Social Services on matters relating to prescribing decisions and medicines management, and was the Vice Chair of its New Medicines Group, which appraises all eligible new, licensed medicines, available for use in the NHS, and which makes recommendations to AWMSG. He has undertaken commissioned work on the evaluation of programs and interventions for a range of organizations, including the World Health Organization, Welsh Government, Department of Health, Department of Work and Pensions and a range of health and social care authorities and pharmaceutical companies. He has published extensively in the field of health economics, health and social policy, with over 230 books and journal articles.

Giuseppe La Torre is full Professor of Occupational Medicine at the Sapienza University of Rome, Italy; since September 2019, he is the Head of Occupational Medicine Unit at the Teaching Hospital Policlinico Umberto I of Rome, Italy and recently he became also the Head of Occupational Medicine Center at the Sapienza University of Rome, Italy. He graduated in Medicine and specialized in Hygiene and Preventive Medicine at the University of Naples “Federico II”. He obtained a Master of Science in Epidemiology and subsequently he became Doctor of Science in Epidemiology at the Erasmus University of Rotterdam, the Netherlands. Professor La Torre authored 613 publications in peer-reviewed journals. He wrote a number of health technology assessment reports on drugs, vaccines, and medical devices.
His main research activities, including design, conduct, and analysis, are in the following areas: occupational medicine, public health, health promotion, nutrition, systematic review and meta-analysis, tobacco smoking, cardiovascular epidemiology, cancer epidemiology, genetic epidemiology, and injury epidemiology. He lives in Rome, Italy.

Dr. Holtorf is the founder of the Health Outcomes Strategies GmbH consulting agency (www.health-os.com) with focus on value of healthcare products and related policy decisions for the in- and off-patent sector, reimbursement strategies, outcomes research and health economics, health technology assessment processes, payer interactions, product/device/service synergies. Dr. Holtorf acted as evaluator at the EU-commission on multiple occasions and is adjunct faculty member at the University of Utah College of Pharmacy. She is engaged in workgroups for Precision Medicines Value (ISPOR), for Digital Health (ISPOR) and for Patient and Citizen Involvement (PCI) in HTA (in Steering Committee and as project coordinator for PCIG at the international HTA association, HTAi) and serves in the Business Development Committee of HTAi.